▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] Medytox has sent out a pilot batch of its liquid-type botulinum toxin Innotox to its US partner Allergan to initiate the long-awaited phase 3 clinical trials of the drug candidate tha...
[THE INVESTOR] Wrapping up a month-long review, the country’s top financial regulator is poised to hold the final session of Samsung BioLogics ' alleged accounting irregularities on May 31 before ...
[THE INVESTOR] Samsung BioLogics CEO Kim Tae-han attended the second round of meeting with financial authorities on May 25 to make another attempt to allay suspicions of exaggerating the value of i...
[THE INVESTOR] Celltrion Healthcare , which handles Celltrion’s overseas business, has pulled itself out of the red by reporting a net profit of 60.5 billion won (US$56.06 million) for the first qu...
[THE INVESTOR] Feelux said on May 24 that it will establish a subsidiary in the US in a bid to accelerate the development of immunotherapy for cancer. The board of of directors has decided to make...
[THE INVESTOR] Samsung BioLogics said on May 24 that the production of a third monoclonal antibody drug substance has been approved by the US Food and Drug Administration for its second plant. Wit...
[THE INVESTOR] JW Holdings said on May 23 it has signed export deals with Brazil-based Sif Participacoe and India’s Alniche Lifescience to venture into emerging markets. The Korean company will sup...
[THE INVESTOR] Over the past three weeks, Samsung BioLogics has been facing drastic changes inside and out after the country’s financial authorities alleged that it had intentionally misapplied an a...
[THE INVESTOR] Korean drug company GC Pharma set up vaccine manufacturer Curevo in the United States toward the end of last year, industry sources reported for the first time on May 21. The Seat...
[THE INVESTOR] Samsung BioLogics said on May 18 that Biogen Therapeutics has confirmed that it will increase its stake in their joint venture Samsung Bioepis up to nearly 50 percent in a move that ...
[THE INVESTOR] Samsung BioLogics CEO Kim Tae-han on May 17 voiced his discomfort with the country’s financial regulator which alleged that the company had broken accounting rules en route to a meet...
[THE INVESTOR] The financial authorities and Samsung BioLogics on May 17 held their first session reviewing a regulatory probe into the biotechnology firm over suspected accounting breaches, officia...
[THE INVESTOR] The US Food and Drug Administration has rejected Daewoong Pharmaceutical’s application seeking approval of its botulinum toxin Nabota, also known as DWP-450, the company said on May 1...
[THE INVESTOR] A high-profile hearing will be held on May 17 to determine whether contract drug manufacturer Samsung BioLogics had committed accounting irregularities in order to inflate earnings be...
[THE INVESTOR] Korean pharmaceutical companies have posted hefty returns from their equity investments in domestic and foreign bio startups, data showed on May 16. According to the data from the...
Samsung Galaxy Note 10 to beat Apple’s iPhone XS in screen size
SKT, Samsung complete first 5G call
CJ CGV’s Vietnam unit to slow down IPO process
Schindler sues Korean gov’t over Hyundai Elevator
KKR, Shinhan Financial in strategic partnership
Dream Gream offers taste of real art world, broadens aspirants’ horizons
CJ ENM joins forces with Bluehole for expansion in US
Heads of Hanwha, Heritage Foundation call for stronger US-Korea alliance
October 16, 2018
